Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis

Nitin J. Karandikar(National Institute of Allergy and Infectious Diseases), Michael K. Racke(Quest Diagnostics (United States)), Richard A. Koup(Aaron Diamond AIDS Research Center), Robert B. Ratts(Vir Biotechnology (Switzerland)), David R. Ambrozak(National Institute of Allergy and Infectious Diseases), Daniel C. Douek(Institut de Recherche Vaccinale), Elliot M. Frohman(Stanford University), Amy E. Lovett‐Racke(The Ohio State University Wexner Medical Center), Xiao‐Jie Yan, Jason M. Brenchley(Office of Extramural Research), Michael P. Crawford, Peter Šťastný(The University of Texas Southwestern Medical Center)
Journal of Clinical Investigation
March 1, 2002
Cited by 175


Related Papers